Accretion Nutrav

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE1KVQ01019
  • NSEID:
  • BSEID: 544694
INR
268.50
7 (2.68%)
BSENSE

Jun 03, 03:30 PM

BSE+NSE Vol: 7000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

7.0 k (218.18%) Volume

Shareholding (Mar 2026)

FII

1.08%

Held by 1 FIIs

DII

7.00%

Held by 0 DIIs

Promoter

73.48%

When is the next results date for Accretion Nutraveda Ltd?

05-May-2026

The next results date for Accretion Nutraveda Ltd is 08 May 2026.

The next results date for Accretion Nutraveda Ltd is scheduled for 08 May 2026.

View full answer

Why is Accretion Nutraveda Ltd falling/rising?

03-Jun-2026

As of 02-Jun, the stock price of Accretion Nutraveda Ltd is at 261.50, unchanged from the previous session, but has declined 0.91% over the past week. Despite being above longer-term moving averages, the stock shows short-term weakness with decreased trading volume and inconsistent investor interest.

As of 02-Jun, the stock price of Accretion Nutraveda Ltd is currently at 261.50, showing no change from the previous trading session. The stock has experienced a decline of 0.91% over the past week, which is better than the Sensex's drop of 1.79%. However, in the last month, the stock has fallen by 2.24%, while the Sensex has decreased by 2.94%. <BR><BR>Today, the stock opened with a loss of 3.37% and reached an intraday low of Rs 250.75, marking a decline of 4.98%. This erratic trading pattern is evident as the stock did not trade on three days out of the last twenty, indicating a lack of consistent investor interest. Additionally, the delivery volume has significantly decreased, with a reported drop of 61.54% against the five-day average, suggesting falling investor participation. <BR><BR>Despite the stock being above its 20-day, 50-day, 100-day, and 200-day moving averages, it is currently below its 5-day moving average, which may indicate short-term weakness. The weighted average price reflects that more volume was traded closer to the low price, further supporting the notion of downward pressure on the stock. Overall, these factors contribute to the current stagnation and slight decline in the stock's performance.

View full answer

Which are the latest news on Accretion Nutrav?

03-Jun-2026

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 189 Cr (Micro Cap)

stock-summary
P/E

38.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

0.00

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
35.26%
0%
35.26%
6 Months
0%
0%
0.0%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Accretion Nutrav for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Press Release / Media Release

15-May-2026 | Source : BSE

Accretion Nutraveda Limited has informed the Exchange regarding Press Release dated 15th May 2026 titled Company Delivers Robust Performance in H2 FY26 : Revenue up 80.09% YOY and EBITDA up 42.64% and growth Driven by strong demand Operational Expansion and Expanding Market Presence.

Announcement under Regulation 30 (LODR)-Resignation of Director

08-May-2026 | Source : BSE

Please find enclosed herewith resignation of Mr. Mahipal singh chouhan as non-Executive Independent Director of the Company.

Appointment Of Internal Auditors

08-May-2026 | Source : BSE

Please find enclosed herewith Intimation with respect to Appointment Internal Auditor of the company.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
3.70
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
18.36%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
8.08%
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
38
Industry P/E
33
Price to Book Value
NA
EV to EBIT
29.32
EV to EBITDA
28.21
EV to Capital Employed
NA
EV to Sales
5.79
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
NA
ROE (Latest)
NA

Technicals key factors

Indicator
Weekly
Monthly
MACD
RSI
No Signal
Bollinger Bands
KST
Dow Theory
No Trend
OBV
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 1 FIIs (1.08%)

Promoter with highest holding

Ankurkumar Shantilal Patel (14.7%)

Highest Public shareholder

Unicorn Fund (6.59%)

Individual Investors Holdings

14.19%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Accretion Nutrav"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Mar 2026 is 38.98% vs 29.59% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Mar 2026 is 15.45% vs 35.47% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "19.54",
          "val2": "14.06",
          "chgp": "38.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.56",
          "val2": "3.29",
          "chgp": "8.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.27",
          "val2": "0.26",
          "chgp": "3.85%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "2.69",
          "val2": "2.33",
          "chgp": "15.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.22%",
          "val2": "23.40%",
          "chgp": "-5.18%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Accretion Nutrav"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 110.00% vs 219.36% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 102.80% vs 204.88% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "33.60",
          "val2": "16.00",
          "chgp": "110.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "6.89",
          "val2": "3.72",
          "chgp": "85.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.53",
          "val2": "0.35",
          "chgp": "51.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "5.07",
          "val2": "2.50",
          "chgp": "102.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.51%",
          "val2": "23.25%",
          "chgp": "-2.74%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Half Yearly Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Sep'25
Change(%)
Net Sales
19.54
14.06
38.98%
Operating Profit (PBDIT) excl Other Income
3.56
3.29
8.21%
Interest
0.27
0.26
3.85%
Exceptional Items
0.00
0.00
Standalone Net Profit
2.69
2.33
15.45%
Operating Profit Margin (Excl OI)
18.22%
23.40%
-5.18%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Mar 2026 is 38.98% vs 29.59% in Sep 2025

Direction Arrows
Standalone Net Profit

Growth in half year ended Mar 2026 is 15.45% vs 35.47% in Sep 2025

Annual Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
33.60
16.00
110.00%
Operating Profit (PBDIT) excl Other Income
6.89
3.72
85.22%
Interest
0.53
0.35
51.43%
Exceptional Items
0.00
0.00
Standalone Net Profit
5.07
2.50
102.80%
Operating Profit Margin (Excl OI)
20.51%
23.25%
-2.74%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 110.00% vs 219.36% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2026 is 102.80% vs 204.88% in Mar 2025

stock-summaryCompany CV
About Accretion Nutraveda Ltd stock-summary
stock-summary
Accretion Nutraveda Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Accretion Nutraveda Limited was initially incorporated as a Private Limited Company on March 16, 2021 and has subsequently, converted the status into a Public Limited Company vide Certificate of Incorporation issued by the Registrar of Companies, Central Processing Centre w.e.f. May 2, 2025.
Company Coordinates stock-summary
Icon
No Company Details Available